Sidniः Australia's government said Tuesday that it has decided not to buy vaccine corona virus with a single dose of Johnson & Johnson. On the other hand, there has been a second case of blood clotting, which is probably related to the AstraZeneca vaccine. Negotiations between Johnson & Johnson, the New Jersey drug company, and the government were underway. The company requested temporary registration from the Australian Regulatory Therapeutic Goods Administration.
However, Health Minister Greg Hunt has ruled out the possibility of a contract with the company as its vaccine resembles the product of AstraZeneca with which Australia has already contracted for 5.38 crore doses. He said the government was working on the advice of the Scientific and Technology Consulting Group of Australia. Australia has been successful in controlling the virus to a great extent, but has been criticized for the sluggish pace of vaccination.
The regulator said that a person in the state of Victoria here was admitted to the hospital after complaining of a blood clot. He was vaccinated with AstraZeneca on 22 March. Another such case came to light on Tuesday. A woman complained of a blood clot after vaccination and has also been admitted to a hospital.